AKT1 and neoplasm: The identified Rac and Cdc42 selective inhibitors are effective in cell culture [28, 30, 34, 121, 122] and recent studies demonstrate anti-tumor activity in mouse xenograft models [32, 33], but these compounds have not been translated to human use.